Literature DB >> 26260798

Matrix cross-linking lysyl oxidases are induced in response to myocardial infarction and promote cardiac dysfunction.

José González-Santamaría1, María Villalba2, Oscar Busnadiego1, Marina M López-Olañeta2, Pilar Sandoval1, Jessica Snabel3, Manuel López-Cabrera1, Janine T Erler4, Roeland Hanemaaijer3, Enrique Lara-Pezzi5, Fernando Rodríguez-Pascual6.   

Abstract

AIMS: After myocardial infarction (MI), extensive remodelling of the extracellular matrix contributes to scar formation. While aiming to preserve tissue integrity, this fibrotic response is also associated with adverse events, including a markedly increased risk of heart failure, ventricular arrhythmias, and sudden cardiac death. Cardiac fibrosis is characterized by extensive deposition of collagen and also by increased stiffness as a consequence of enhanced collagen cross-linking. Members of the lysyl oxidase (LOX) family of enzymes are responsible for the formation of collagen cross-links. This study investigates the contribution of LOX family members to the heart response to MI. METHODS AND
RESULTS: Experimental MI was induced in C57BL/6 mice by permanent ligation of the left anterior descending coronary artery. The expression of LOX isoforms (LOX and LOXL1-4) was strongly increased upon MI, and this response was accompanied by a significant accumulation of mature collagen fibres in the infarcted area. LOX expression was observed in areas of extensive remodelling, partially overlapping with α-smooth muscle actin-expressing myofibroblasts. Tumour growth factor-β as well as hypoxia-activated pathways contributed to the induction of LOX expression in cardiac fibroblasts. Finally, in vivo post-infarction treatment with the broadband LOX inhibitor β-aminopropionitrile or, selectively, with a neutralizing antibody against the canonical LOX isoform attenuated collagen accumulation and maturation and also resulted in reduced ventricular dilatation and improved cardiac function.
CONCLUSION: LOX family members contribute significantly to the detrimental effects of cardiac remodelling, highlighting LOX inhibition as a potential therapeutic strategy for post-infarction recovery. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2015. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Cardiac fibrosis; Collagen; Lysyl oxidases; Myocardial infarction; Myofibroblast

Mesh:

Substances:

Year:  2015        PMID: 26260798     DOI: 10.1093/cvr/cvv214

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  44 in total

1.  Decreased lysyl oxidase level protects against development of retinal vascular lesions in diabetic retinopathy.

Authors:  Dongjoon Kim; Robert P Mecham; Ngan-Ha Nguyen; Sayon Roy
Journal:  Exp Eye Res       Date:  2019-05-06       Impact factor: 3.467

2.  CD8+ T-cells negatively regulate inflammation post-myocardial infarction.

Authors:  Daria V Ilatovskaya; Cooper Pitts; Joshua Clayton; Mark Domondon; Miguel Troncoso; Sarah Pippin; Kristine Y DeLeon-Pennell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-07-19       Impact factor: 4.733

3.  Macrophage overexpression of matrix metalloproteinase-9 in aged mice improves diastolic physiology and cardiac wound healing after myocardial infarction.

Authors:  Cesar A Meschiari; Mira Jung; Rugmani Padmanabhan Iyer; Andriy Yabluchanskiy; Hiroe Toba; Michael R Garrett; Merry L Lindsey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-10-13       Impact factor: 4.733

4.  Sustained release of basic fibroblast growth factor using gelatin hydrogel improved left ventricular function through the alteration of collagen subtype in a rat chronic myocardial infarction model.

Authors:  Zipeng Li; Hidetoshi Masumoto; Jun-Ichiro Jo; Kazuhiro Yamazaki; Tadashi Ikeda; Yasuhiko Tabata; Kenji Minatoya
Journal:  Gen Thorac Cardiovasc Surg       Date:  2018-07-07

5.  A hierarchical network of hypoxia-inducible factor and SMAD proteins governs procollagen lysyl hydroxylase 2 induction by hypoxia and transforming growth factor β1.

Authors:  Tamara Rosell-García; Oscar Palomo-Álvarez; Fernando Rodríguez-Pascual
Journal:  J Biol Chem       Date:  2019-08-07       Impact factor: 5.157

Review 6.  Mechano-therapeutics: Targeting Mechanical Signaling in Fibrosis and Tumor Stroma.

Authors:  Daniel J Tschumperlin; David Lagares
Journal:  Pharmacol Ther       Date:  2020-05-11       Impact factor: 12.310

7.  Inhibitor of lysyl oxidase improves cardiac function and the collagen/MMP profile in response to volume overload.

Authors:  Elia C El Hajj; Milad C El Hajj; Van K Ninh; Jason D Gardner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-05-18       Impact factor: 4.733

Review 8.  Understanding cardiac extracellular matrix remodeling to develop biomarkers of myocardial infarction outcomes.

Authors:  Signe Holm Nielsen; Alan J Mouton; Kristine Y DeLeon-Pennell; Federica Genovese; Morten Karsdal; Merry L Lindsey
Journal:  Matrix Biol       Date:  2017-12-14       Impact factor: 11.583

Review 9.  Lysyl Oxidase Isoforms and Potential Therapeutic Opportunities for Fibrosis and Cancer.

Authors:  Philip C Trackman
Journal:  Expert Opin Ther Targets       Date:  2016-03-03       Impact factor: 6.902

Review 10.  Matrix Stiffness: the Conductor of Organ Fibrosis.

Authors:  Alba Santos; David Lagares
Journal:  Curr Rheumatol Rep       Date:  2018-01-19       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.